Nishio W - Search Results

1

Avian-type receptor-binding ability can increase influenza virus pathogenicity in macaques.

Watanabe T, Shinya K, Watanabe S, Imai M, Hatta M, Li C, Wolter BF, Neumann G, Hanson A, Ozawa M, Yamada S, Imai H, Sakabe S, Takano R, Iwatsuki-Horimoto K, Kiso M, Ito M, Fukuyama S, Kawakami E, Gorai T, Simmons HA, Schenkman D, Brunner K, Capuano SV 3rd, Weinfurter JT, Nishio W, Maniwa Y, Igarashi T, Makino A, Travanty EA, Wang J, Kilander A, Dudman SG, Suresh M, Mason RJ, Hungnes O, Friedrich TC, Kawaoka Y. Watanabe T, et al. Among authors: nishio w. J Virol. 2011 Dec;85(24):13195-203. doi: 10.1128/JVI.00859-11. Epub 2011 Sep 21. J Virol. 2011. PMID: 21937653 Free PMC article.

2

Application of hRad9 in lung cancer treatment as a molecular marker and a molecular target.

Maniwa Y, Nishio W, Yoshimura M. Maniwa Y, et al. Among authors: nishio w. Thorac Cancer. 2011 Feb;2(1):7-15. doi: 10.1111/j.1759-7714.2010.00036.x. Thorac Cancer. 2011. PMID: 27755837 Free article. Review.

3

The optimal timing to resect pulmonary metastasis.

Tanaka Y, Maniwa Y, Nishio W, Yoshimura M, Okita Y. Tanaka Y, et al. Among authors: nishio w. Eur J Cardiothorac Surg. 2008 Jun;33(6):1135-8. doi: 10.1016/j.ejcts.2008.03.002. Epub 2008 Apr 8. Eur J Cardiothorac Surg. 2008. PMID: 18396056

4

DNA damage sensor protein hRad9, a novel molecular target for lung cancer treatment.

Yuki T, Maniwa Y, Doi T, Okada K, Nishio W, Hayashi Y, Okita Y. Yuki T, et al. Among authors: nishio w. Oncol Rep. 2008 Nov;20(5):1047-52. Oncol Rep. 2008. PMID: 18949400

5

Overexpression of Necl-5 correlates with unfavorable prognosis in patients with lung adenocarcinoma.

Nakai R, Maniwa Y, Tanaka Y, Nishio W, Yoshimura M, Okita Y, Ohbayashi C, Satoh N, Ogita H, Takai Y, Hayashi Y. Nakai R, et al. Among authors: nishio w. Cancer Sci. 2010 May;101(5):1326-30. doi: 10.1111/j.1349-7006.2010.01530.x. Epub 2010 Feb 11. Cancer Sci. 2010. PMID: 20331633 Free article.

6

Successful management of descending necrotizing mediastinitis.

Wakahara T, Tanaka Y, Maniwa Y, Nishio W, Yoshimura M. Wakahara T, et al. Among authors: nishio w. Asian Cardiovasc Thorac Ann. 2011 Jun;19(3-4):228-31. doi: 10.1177/0218492311408641. Asian Cardiovasc Thorac Ann. 2011. PMID: 21885547

7

Chemosensitivity of lung cancer: Differences between the primary lesion and lymph node metastasis.

Maniwa Y, Yoshimura M, Hashimoto S, Takata M, Nishio W. Maniwa Y, et al. Among authors: nishio w. Oncol Lett. 2010 Mar;1(2):345-349. doi: 10.3892/ol_00000061. Epub 2010 Mar 1. Oncol Lett. 2010. PMID: 22966306 Free PMC article.

8

The role of Necl-5 in the invasive activity of lung adenocarcinoma.

Tane S, Maniwa Y, Hokka D, Tauchi S, Nishio W, Okita Y, Yoshimura M. Tane S, et al. Among authors: nishio w. Exp Mol Pathol. 2013 Apr;94(2):330-5. doi: 10.1016/j.yexmp.2012.12.003. Epub 2012 Dec 28. Exp Mol Pathol. 2013. PMID: 23276719

9

Expression of nectin 3: Novel prognostic marker of lung adenocarcinoma.

Maniwa Y, Nishio W, Okita Y, Yoshimura M. Maniwa Y, et al. Among authors: nishio w. Thorac Cancer. 2012 May;3(2):175-181. doi: 10.1111/j.1759-7714.2011.00104.x. Thorac Cancer. 2012. PMID: 28920296 Free article.

10

Segmental volumetric analysis with a ventilated or perfused area: identifying the intersegmental plane.

Kitazume M, Tane S, Shimizu N, Kitamura Y, Maniwa Y, Nishio W. Kitazume M, et al. Among authors: nishio w. Eur J Cardiothorac Surg. 2022 Nov 3;62(6):ezac537. doi: 10.1093/ejcts/ezac537. Eur J Cardiothorac Surg. 2022. PMID: 36370071

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page